BGI Genomics Co Ltd Capital Reinvestment Ratio
BGI Genomics Co Ltd capital reinvestment ratio. BGI Genomics Co Ltd (300676) has a Capital Reinvestment Ratio of 0.69x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥238.54 Million) in capital expenditures (CN¥165.34 Million). See BGI Genomics Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of BGI Genomics Co Ltd (2012–2024)
Capital reinvestment ratio of BGI Genomics Co Ltd from 2012 to 2024. This chart tracks BGI Genomics Co Ltd's Capital Reinvestment Ratio across 12 annual periods. See BGI Genomics Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
BGI Genomics Co Ltd Capital Reinvestment Ratio by Year (2012–2024)
BGI Genomics Co Ltd capital reinvestment ratio by year from 2012 to 2024. For the full cash flow conversion analysis, see BGI Genomics Co Ltd cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 5.53x | CN¥95.72 Million | CN¥529.48 Million | ▲ +82.9% |
| 2023 | 3.02x | CN¥408.77 Million | CN¥1.24 Billion | ▼ -68.7% |
| 2022 | 9.68x | CN¥130.88 Million | CN¥1.27 Billion | ▲ +6148.1% |
| 2021 | 0.15x | CN¥2.48 Billion | CN¥383.52 Million | ▲ +85.3% |
| 2020 | 0.08x | CN¥3.60 Billion | CN¥301.15 Million | ▼ -97.0% |
| 2019 | 2.79x | CN¥224.25 Million | CN¥626.44 Million | ▼ -93.9% |
| 2018 | 46.17x | CN¥14.69 Million | CN¥678.13 Million | ▲ +3761.6% |
| 2017 | 1.20x | CN¥243.66 Million | CN¥291.33 Million | ▲ +13.8% |
| 2016 | 1.05x | CN¥234.07 Million | CN¥246.01 Million | ▲ +94.9% |
| 2015 | 0.54x | CN¥328.68 Million | CN¥177.26 Million | ▼ -93.1% |
| 2013 | 7.76x | CN¥36.70 Million | CN¥284.88 Million | ▲ +809.1% |
| 2012 | 0.85x | CN¥72.49 Million | CN¥61.89 Million | — |